NCT05112601 2026-04-21Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial CarcinomaNational Cancer Institute (NCI)Phase 2 Recruiting81 enrolled